VIVXF

Healthcare Drug Manufacturers - Specialty & Generic

Avivagen Inc.

$0.00

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

12,509.196

Avg Volume

EPS

-$0.04

52W High

$0.00

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-0.00

P/S Ratio

0.02

EV/EBITDA

-2.40

EV/Revenue

10.10

Margins

Gross Margin 42.7%

Operating Margin (1047.4%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(16.6%)

Return on Assets

(193.4%)

Liquidity & Leverage

Current Ratio

0.03

Quick Ratio

0.01

Total Cash

17,183

Total Debt

7.24M

About

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia, and Malaysia. The company is headquartered in Ottawa, Canada.